TD Asset Management
PACB icon

TD Asset Management’s Pacific Biosciences PACB Stock Holding History

TD Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-292,686
Closed -$536K – 1255
2024
Q4 		$536K Hold
292,686
– – ﹤0.01% 1179
2024
Q3 		$512K Hold
292,686
– – ﹤0.01% 1298
2024
Q2 		$401K Sell
292,686
-240,814
-45% -$486K ﹤0.01% 1299
2024
Q1 		$2M Sell
533,500
-127,800
-19% -$748K ﹤0.01% 1024
2023
Q4 		$6.49M Sell
661,300
-43,400
-6% -$355K 0.01% 695
2023
Q3 		$5.88M Buy
704,700
+285,343
+68% +$3.26M 0.01% 700
2023
Q2 		$5.58M Buy
419,357
+18,985
+5% +$231K 0.01% 714
2023
Q1 		$4.64M Buy
400,372
+33,794
+9% +$336K 0.01% 766
2022
Q4 		$3M Buy
366,578
+73,368
+25% +$632K ﹤0.01% 872
2022
Q3 		$1.64M Buy
293,210
+104,152
+55% +$598K ﹤0.01% 1064
2022
Q2 		$836K Sell
189,058
-79,600
-30% -$484K ﹤0.01% 1211
2022
Q1 		$2.44M Buy
268,658
+31,223
+13% +$359K ﹤0.01% 1025
2021
Q4 		$4.86M Buy
237,435
+4,666
+2% +$113K ﹤0.01% 878
2021
Q3 		$5.95M Buy
232,769
+4,217
+2% +$125K 0.01% 779
2021
Q2 		$7.35M Buy
228,552
+3,598
+2% +$105K 0.01% 732
2021
Q1 		$7.49M Buy
224,954
+30,227
+16% +$1.06M 0.01% 714
2020
Q4 		$5.05M Buy
194,727
+77,056
+65% +$1.31M 0.01% 787
2020
Q3 		$1.16M Buy
+117,671
New +$677K ﹤0.01% 1061

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TD Asset Management's PACB Position: Q1 2025 in Review

TD Asset Management sold out of Pacific Biosciences (PACB) in Q1 2025, closing a stake of 292,686 shares — an estimated $536K sold.

TD Asset Management first reported a position in PACB in Q3 2020 and held it in 18 quarters. The position peaked at $7.49M in Q1 2021. 225 funds tracked by Wall St. Rank hold PACB as of Q1 2025.

  • TD Asset Management reported no remaining Pacific Biosciences position as of Q1 2025 after selling out during the quarter.
  • TD Asset Management sold 292,686 Pacific Biosciences shares in Q1 2025, an estimated $536K.
  • TD Asset Management first reported a position in Pacific Biosciences in Q3 2020 and held it in 18 quarters.
  • TD Asset Management's Pacific Biosciences position peaked at $7.49M in Q1 2021.
  • 225 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2025.

Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.